Zimmer Biomet Holdings, Inc.
ZBH
$100.91
$1.431.44%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.51B | 8.41B | 8.23B | 8.01B | 7.83B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.51B | 8.41B | 8.23B | 8.01B | 7.83B |
| Cost of Revenue | 2.55B | 2.51B | 2.50B | 2.28B | 2.26B |
| Gross Profit | 5.95B | 5.90B | 5.73B | 5.73B | 5.58B |
| SG&A Expenses | 3.38B | 3.30B | 3.21B | 3.08B | 2.97B |
| Depreciation & Amortization | 679.70M | 676.90M | 665.80M | 645.70M | 617.40M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.05B | 6.94B | 6.83B | 6.45B | 6.29B |
| Operating Income | 1.46B | 1.47B | 1.40B | 1.56B | 1.54B |
| Income Before Tax | 933.50M | 903.00M | 830.80M | 1.02B | 973.20M |
| Income Tax Expenses | 126.60M | 142.30M | 125.80M | 214.60M | 147.70M |
| Earnings from Continuing Operations | 806.90 | 760.70 | 705.00 | 807.40 | 825.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -300.00K | 400.00K | 0.00 | -2.20M | -2.10M |
| Net Income | 806.60M | 761.10M | 705.00M | 805.20M | 823.40M |
| EBIT | 1.46B | 1.47B | 1.40B | 1.56B | 1.54B |
| EBITDA | 2.56B | 2.58B | 2.49B | 2.64B | 2.59B |
| EPS Basic | 4.12 | 3.87 | 3.56 | 4.06 | 4.12 |
| Normalized Basic EPS | 3.77 | 3.76 | 3.55 | 4.00 | 3.98 |
| EPS Diluted | 4.12 | 3.86 | 3.55 | 4.03 | 4.10 |
| Normalized Diluted EPS | 3.76 | 3.75 | 3.53 | 3.98 | 3.97 |
| Average Basic Shares Outstanding | 782.50M | 788.20M | 792.10M | 794.00M | 798.20M |
| Average Diluted Shares Outstanding | 785.50M | 791.00M | 794.90M | 796.70M | 800.90M |
| Dividend Per Share | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| Payout Ratio | 23.36% | 24.89% | 26.99% | 23.70% | 23.38% |